---
figid: PMC8576662__atm-09-20-1601-f1
figtitle: Narrative review of the relationship between TGFB signaling and gynecological
  malignant tumor
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8576662
filename: atm-09-20-1601-f1.jpg
figlink: /pmc/articles/PMC8576662/figure/f1/
number: F1
caption: The role of TGF-β signaling pathway in cancer. In the SMAD-dependent pathway
  (right), TGF-β binds to TGFβR-II and phosphorylates TGFβR-I, which activates SMAD2
  and SMAD3. The activated SMAD2/3 forms a complex with SMAD4, which enters the nucleus
  in the early and advanced stages of tumorigenesis, interacts with various transcription
  factors and transcription co-activators, and regulates the transcription of the
  target gene. SMAD7 antagonizes TGF-β-delivery signals by blocking SMAD2/3 activation
  and interfering with the formation of the SMAD2/3/4 complex. In the SMAD-independent
  pathway (left), TGF-β signaling can also regulate cellular responses through non-SMAD
  signaling pathways, such as p38/MAPK, ERK/MAPK, NF-κB, JNK, PI3K/AKT, and RhoA-Rock1,
  etc. TGF-β, transforming growth factor-β.
papertitle: A narrative review of the relationship between TGF-β signaling and gynecological
  malignant tumor.
reftext: Fangyuan Luo, et al. Ann Transl Med. 2021 Oct;9(20):1601.
year: '2021'
doi: 10.21037/atm-21-4879
journal_title: Annals of Translational Medicine
journal_nlm_ta: Ann Transl Med
publisher_name: AME Publishing Company
keywords: Malignant tumor | signal transduction | transforming growth factor-β (TGF-β)
  | SMAD | gynecology
automl_pathway: 0.955863
figid_alias: PMC8576662__F1
figtype: Figure
redirect_from: /figures/PMC8576662__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8576662__atm-09-20-1601-f1.html
  '@type': Dataset
  description: The role of TGF-β signaling pathway in cancer. In the SMAD-dependent
    pathway (right), TGF-β binds to TGFβR-II and phosphorylates TGFβR-I, which activates
    SMAD2 and SMAD3. The activated SMAD2/3 forms a complex with SMAD4, which enters
    the nucleus in the early and advanced stages of tumorigenesis, interacts with
    various transcription factors and transcription co-activators, and regulates the
    transcription of the target gene. SMAD7 antagonizes TGF-β-delivery signals by
    blocking SMAD2/3 activation and interfering with the formation of the SMAD2/3/4
    complex. In the SMAD-independent pathway (left), TGF-β signaling can also regulate
    cellular responses through non-SMAD signaling pathways, such as p38/MAPK, ERK/MAPK,
    NF-κB, JNK, PI3K/AKT, and RhoA-Rock1, etc. TGF-β, transforming growth factor-β.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - dpp
  - gbb
  - put
  - mav
  - Gfrl
  - Erk7
  - rl
  - MKP-4
  - p38b
  - lic
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - Akt
  - bsk
  - Dif
  - dl
  - Rel
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - et
  - Smox
  - Mad
  - 'On'
  - Med
  - 'Off'
  - Dad
  - TGFB1
  - TGFB2
  - TGFB3
  - TGFBR2
  - EPHB2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - GRAP2
  - AHSA1
  - POLDIP2
  - AKT1
  - AKT2
  - AKT3
  - NFKB1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SPP1
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - TGFBR1
---
